Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype directed therapy in murine mismatch repair deficient tumors.

PloS one - 1 Jan 2013

Kucherlapati Melanie H, Esfahani Shadi, Habibollahi Peiman, Wang Junning, Still Eric R, Bronson Roderick T, Mahmood Umar, Kucherlapati Raju S

Abstract excerpt

The PI3K/AKT/mTOR pathway has frequently been found activated in human tumors. We show that in addition to Wnt signaling dysfunction, the PI3K/AKT/mTOR pathway is often upregulated in mouse Msh2(-/-) initiated intestinal tumors. NVP-BEZ235 is a dual PI3K/mTOR inhibitor toxic to many cancer cell l...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mismatch Repair
Share to Imidazoles
Share to Integrases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intestinal Neoplasms

Share to MutS Homolog 2 Protein

Share to Positron-Emission Tomography

Share to Quinolines

Share to Wnt Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 23935891
DOI: 10.1371/journal.pone.0068817
PMCID: PMC3720855

Genes

PDPK1
PTEN

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23935891-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype directed therapy in murine mismatch repair deficient tumors.PMID 23935891Read ↗

RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.Semantic proximity Read ↗

Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous.Semantic proximity Read ↗

Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.Semantic proximity Read ↗

Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).Semantic proximity Read ↗

Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.Semantic proximity Read ↗

Mouse models of Kras-mutant colorectal cancer: valuable GEMMs for drug testing?Semantic proximity Read ↗

Mouse models of DNA mismatch repair in cancer research.Semantic proximity Read ↗

Genetically engineered mouse models of PI3K signaling in breast cancerSemantic proximity Read ↗

Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.Semantic proximity Read ↗

Functional consequences of DNA mismatch repair missense mutations in murine models and their impact on cancer predisposition.Semantic proximity Read ↗

Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.Semantic proximity Read ↗

Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.